ADARx Pharmaceuticals, Inc. (ADRX)
Nasdaq: ADRX · CIK 0001802369 · United States
Every official ADARx Pharmaceuticals, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open ADRX filings
ADARx Pharmaceuticals, Inc. documents
- ADARx Pharmaceuticals, Inc. 10-K 2026ADRX 10-K 2026: annual report for fiscal 2026
- ADARx Pharmaceuticals, Inc. 10-K 2025ADRX 10-K 2025: annual report for fiscal 2025
- ADARx Pharmaceuticals, Inc. 10-K 2024ADRX 10-K 2024: annual report for fiscal 2024
- ADARx Pharmaceuticals, Inc. 10-K 2023ADRX 10-K 2023: annual report for fiscal 2023
- ADARx Pharmaceuticals, Inc. 10-K 2022ADRX 10-K 2022: annual report for fiscal 2022
- ADARx Pharmaceuticals, Inc. 10-Q 2026ADRX 10-Q 2026: quarterly report for fiscal 2026
- ADARx Pharmaceuticals, Inc. 10-Q 2025ADRX 10-Q 2025: quarterly report for fiscal 2025
- ADARx Pharmaceuticals, Inc. 10-Q 2024ADRX 10-Q 2024: quarterly report for fiscal 2024
- ADARx Pharmaceuticals, Inc. 10-Q 2023ADRX 10-Q 2023: quarterly report for fiscal 2023
- ADARx Pharmaceuticals, Inc. 10-Q 2022ADRX 10-Q 2022: quarterly report for fiscal 2022
- ADARx Pharmaceuticals, Inc. 8-K 2026ADRX 8-K 2026: current report for fiscal 2026
- ADARx Pharmaceuticals, Inc. 8-K 2025ADRX 8-K 2025: current report for fiscal 2025
- ADARx Pharmaceuticals, Inc. 8-K 2024ADRX 8-K 2024: current report for fiscal 2024
- ADARx Pharmaceuticals, Inc. 8-K 2023ADRX 8-K 2023: current report for fiscal 2023
- ADARx Pharmaceuticals, Inc. 8-K 2022ADRX 8-K 2022: current report for fiscal 2022
- ADARx Pharmaceuticals, Inc. DEF 14A 2026ADRX DEF 14A 2026: proxy statement for fiscal 2026
- ADARx Pharmaceuticals, Inc. DEF 14A 2025ADRX DEF 14A 2025: proxy statement for fiscal 2025
- ADARx Pharmaceuticals, Inc. DEF 14A 2024ADRX DEF 14A 2024: proxy statement for fiscal 2024
- ADARx Pharmaceuticals, Inc. DEF 14A 2023ADRX DEF 14A 2023: proxy statement for fiscal 2023
- ADARx Pharmaceuticals, Inc. DEF 14A 2022ADRX DEF 14A 2022: proxy statement for fiscal 2022
- ADARx Pharmaceuticals, Inc. Form 4 2026ADRX Form 4 2026: insider trading filing for fiscal 2026
- ADARx Pharmaceuticals, Inc. Form 4 2025ADRX Form 4 2025: insider trading filing for fiscal 2025
- ADARx Pharmaceuticals, Inc. Form 4 2024ADRX Form 4 2024: insider trading filing for fiscal 2024
- ADARx Pharmaceuticals, Inc. Form 4 2023ADRX Form 4 2023: insider trading filing for fiscal 2023
- ADARx Pharmaceuticals, Inc. Form 4 2022ADRX Form 4 2022: insider trading filing for fiscal 2022
- ADARx Pharmaceuticals, Inc. S-1 2026ADRX S-1 2026: registration statement for fiscal 2026
- ADARx Pharmaceuticals, Inc. S-1 2025ADRX S-1 2025: registration statement for fiscal 2025
- ADARx Pharmaceuticals, Inc. S-1 2024ADRX S-1 2024: registration statement for fiscal 2024
- ADARx Pharmaceuticals, Inc. S-1 2023ADRX S-1 2023: registration statement for fiscal 2023
- ADARx Pharmaceuticals, Inc. S-1 2022ADRX S-1 2022: registration statement for fiscal 2022
- ADARx Pharmaceuticals, Inc. 13F 2026ADRX 13F 2026: institutional holdings for fiscal 2026
- ADARx Pharmaceuticals, Inc. 13F 2025ADRX 13F 2025: institutional holdings for fiscal 2025
- ADARx Pharmaceuticals, Inc. 13F 2024ADRX 13F 2024: institutional holdings for fiscal 2024
- ADARx Pharmaceuticals, Inc. 13F 2023ADRX 13F 2023: institutional holdings for fiscal 2023
- ADARx Pharmaceuticals, Inc. 13F 2022ADRX 13F 2022: institutional holdings for fiscal 2022
More companies